Review on the Use of Cell Cultures to Study Metabolism, Transport, and Accumulation of Flavonoids: From Mono-Cultures to Co-Culture Systems

Comprehensive Reviews in Food Science and Food Safety

Volumn 14, Issue 6, 2015, Pages 741-754

  Gonzales, Gerard Bryan ^a   Van Camp, John ^a   Vissenaekens, Hanne ^a   Raes, Katleen ^a   Smagghe, Guy ^a   Grootaert, Charlotte ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Absorption; Accumulation; Co culture models flavonoids; in vitro cell models; Metabolism

Indexed keywords

ABSORPTION; BIOCHEMISTRY; CELL CULTURE; FLAVONOIDS; METABOLISM;

ABC TRANSPORTER; ACCUMULATION; BIOACTIVE COMPOUNDS; CO-CULTURE SYSTEM; CO-CULTURES; DISEASE PREVENTION; IN-VITRO; METABOLIC ROUTES;

CELLS;

EID: 84944275874     PISSN: None     EISSN: 15414337     Source Type: Journal    
DOI: 10.1111/1541-4337.12158     Document Type: Article

References (154)

1. Abraham RT, Weiss A. 2004. Timeline - Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat Rev Immunol 4:301-08.
2. Alvarez AI, Real R, Perez M, Mendoza G, Prieto JG, Merino G. 2010. Modulation of the activity of ABC transporters (P-Glycoprotein, MRP2, BCRP) by flavonoids and drug response. J Pharm Sci-Us 99:598-617.
3. Amsler K, Cook JS. 1982. Development of Na+-dependent hexose-transport in a cultured line of porcine kidney-cells. Am J Physiol 242:C94-C101.
4. Andlauer W, Kolb J, Furst P. 2004. Phloridzin improves absorption of genistin in isolated rat small intestine. Clin Nutr 23:989-95.
5. Baran I, Ganea C, Scordino A, Musumeci F, Barresi V, Tudisco S, Privitera S, Grasso R, Condorelli DF, Ursu I, Baran V, Katona E, Mocanu MM, Gulino M, Ungureanu R, Surcel M, Ursaciuc C. 2010. Effects of menadione, hydrogen peroxide, and quercetin on apoptosis and delayed luminescence of human leukemia jurkat T-Cells. Cell Biochem Biophys 58:169-79.
6. Barrington R, Williamson G, Bennett RN, Davis BD, Brodbelt JS, Kroon PA. 2009. Absorption, conjugation and efflux of the flavonoids, kaempferol and galangin, using the intestinal CACO-2/TC7 cell model. J Funct Foods 1:74-87.
7. Benavente-Garcia O, Castillo J. 2008. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 56:6185-205.
8. Berrin JG, McLauchlan WR, Needs P, Williamson G, Puigserver A, Kroon PA, Juge N. 2002. Functional expression of human liver cytosolic beta-glucosidase in Pichia pastoris - Insights into its role in the metabolism of dietary glucosides. Eur J Biochem 269:249-58.
9. Bieger J, Cermak R, Blank R, deBoer VCJ, Hollman PCH, Kamphues J, Wolffram S. 2008. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 138:1417-20.
10. Borman LS, Dumont JN, Hsie AW. 1975. Relationship between cyclic-amp, microtubule organization, and mammalian-cell shape-Studies on Chinese-hamster ovary cells and their variants. Exp Cell Res 91:422-28.
11. Borst P, Elferink RO. 2002. Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537-92.
12. Bouma ME, Rogier E, Verthier N, Labarre C, Feldmann G. 1989. Further cellular investigation of the human hepatoblastoma-derived cell-line Hepg2 - morphology and immunocyto-chemical studies of hepatic-secreted proteins. In Vitro Cell Dev B 25:267-75.
13. Brand W, Schutte ME, Williamson G, vanZanden JJ, Cnubben NHP, Groten JP, vanBladeren PJ, Rietjens IMCM. 2006. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed Pharmacother 60:508-19.
14. Cai X, Lu W, Ye T, Lu M, Wang J, Huo J, Qian S, Wang X, Cao P. 2012. The molecular mechanism of luteolin-induced apoptosis is potentially related to inhibition of angiogenesis in human pancreatic carcinoma cells. Oncol Rep 28:1353-61.
15. Cai XF, Gao SJ, Cai JY, Wu YZ, Deng H. 2009. Artesunate induced morphological and mechanical changes of Jurkat cell studied by AFM. Scanning 31:83-9.
16. Castell-Auvi A, Cedo L, Pallares V, Blay MT, Pinent M, Motilva MJ, Arola L, Ardevol A. 2010. Development of a coculture system to evaluate the bioactivity of plant extracts on pancreatic beta-cells. Planta Med 76:1576-81.
17. Castell-Auví A, Motilva MJ, Macià A, Torrell H, Bladé C, Pinent M, Arola L, Ardévol A. 2010. Organotypic co-culture system to study plant extract bioactivity on hepatocytes. Food Chem 122:775-81.
18. Chabane MN, Al Ahmad A, Peluso J, Muller CD, Ubeaud G. 2009. Quercetin and naringenin transport across human intestinal Caco-2 cells. J Pharm Pharmacol 61:1473-83.
19. Chan LMS, Lowes S, Hirst BH. 2004. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 21:25-51.
20. Chang HK, Shin MS, Yang HY, Lee JW, Kim YS, Lee MH, Kim J, Kim KH, Kim CJ. 2006. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. Biol Pharm Bull 29:1597-602.
21. Cohen E, Ophir I, Shaul YB. 1999. Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci 112:2657-66.
22. Conradi RA, Hilgers AR, Ho NFH, Burton PS. 1991. The influence of peptide structure on transport across Caco-2 cells. Pharm Res 8:1453-60.
23. Cooray HC, Janvilisri T, vanVeen HW, Hladky SB, Barrand MA. 2004. Interaction of the breast cancer resistance protein with plant polyphenols. Biochem Biophys Res Commun 317:269-75.
24. Crozier A, Del Rio D, Clifford MN. 2010. Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 31:446-67.
25. Day AJ, Bao YP, Morgan MRA, Williamson G. 2000a. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 29:1234-43.
26. Day AJ, Canada FJ, Diaz JC, Kroon PA, Mclauchlan R, Faulds CB, Plumb GW, Morgan MRA, Williamson G. 2000b. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468:166-70.
27. Day AJ, DuPont MS, Ridley S, Rhodes M, Rhodes MJC, Morgan MRA, Williamson G. 1998. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett 436:71-5.
28. deLange ECM. 2004. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv Drug Deliv Rev 56:1793-809.
29. Dehn PF, White CM, Conners DE, Shipkey G, Cumbo TA. 2004. Characterization of the human hepatocellular carcinoma (HEPG2) cell line as an in vitro model for cadmium toxicity studies. In Vitro Cell Dev-An 40:172-82.
30. Dietrich CG, Geier A, Elferink RPJO. 2003. ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut 52:1788-95.
31. Diniz A, Escuder-Gilabert L, Lopes NP, Villanueva-Camanas RM, Sagrado S, Medina-Hernandez MJ. 2008. Characterization of interactions between polyphenolic compounds and human serum proteins by capillary electrophoresis. Anal Bioanal Chem 391:625-32.
32. Dufour C, Loonis M, Dangles O. 2007. Inhibition of the peroxidation of linoleic acid by the flavonoid quercetin within their complex with human serum albumin. Free Radic Biol Med 43:241-52.
33. Elias MM, Lunazzi GC, Passamonti S, Gazzin B, Miccio M, Stanta G, Sottocasa GL, Tiribelli C. 1990. Bilitranslocase localization and function in basolateral plasma-membrane of renal proximal tubule in rat. Am J Physiol 259:F559-F64.
34. Epple HJ, Kreusel KM, Hanski C, Schulzke JD, Riecken EO, Fromm M. 1997. Differential stimulation of intestinal mucin secretion by cholera toxin and carbachol. Pflugers Arch Eur J Physiol 433:638-47.
35. Farabegoli F, Papi A, Bartolini G, Ostan R, Orlandi M. 2010. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine 17:356-62.
36. Faria A, Pestana D, Teixeira D, Azevedo J, DeFreitas V, Mateus N, Calhau C. 2010. Flavonoid transport across RBE4 cells: A blood-brain barrier model. Cell Mol Biol Lett 15:234-41.
37. Fiorani M, Guidarelli A, Blasa M, Azzolini C, Candiracci M, Piatti E, Cantoni O. 2010. Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid. J Nutr Biochem 21:397-404.
38. Florani M, Accorsi A, Cantoni O. 2003. Human red blood cells as a natural flavonoid reservoir. Free Radic Res 37:1331-38.
39. Gee JM, DuPont MS, Day AJ, Plumb GW, Williamson G, Johnson IT. 2000. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J Nutr 130:2765-71.
40. Glaeser H, Bujok K, Schmidt I, Fromm MF, Mandery K. 2014. Organic anion transporting polypeptides and organic cation transporter 1 contribute to the cellular uptake of the flavonoid quercetin. N-S Arch Pharmacol 387:883-91.
41. Gonzales GB, Smagghe G, Grootaert C, Zotti M, Raes K, Camp Van J. 2015. Flavonoid interactions during digestion, absorption, distribution and metabolism: a sequential structure-activity/property relationship based approach in the study of bioavailability and bioactivity. Drug Metab Rev In press.
42. Hammond CL, Marchan R, Krance SM, Ballatori N. 2007. Glutathione export during apoptosis requires functional multidrug resistance-associated proteins. J Biol Chem 282:14337-47.
43. Harada M, Kan Y, Naoki H, Fukui Y, Kageyama N, Nakai M, Miki W, Kiso Y. 1999. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. Biosci Biotechnol Biochem 63:973-77.
44. Hennebicq-Reig S, Tetaert D, Soudan B, Kim I, Huet G, Briand G, Richet C, Demeyer D, Degand P. 1997. O-Glycosylation and cellular differentiation in a subpopulation of mucin-secreting HT-29 cell line. Exp Cell Res 235:100-07.
45. Hilgendorf C, Ahlin G, Seithel A, Artursson P, Ungell AL, Karlsson J. 2007. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 35:1333-40.
46. Hilgendorf C, Spahn-Langguth H, Regardh C, Lipka E, Amidon G, Langguth P. 2000. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci 89:63-75.
47. Hirai S, Kim Y II, Goto T, Kang M-S, Yoshimura M, Obata A, Yu R, Kawada T. 2007. Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages. Life Sci 81:1272-79.
48. Hirohashi T, Suzuki H, Chu XY, Tamai I, Tsuji A, Sugiyama Y. 2000. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J Pharmacol Exp Ther 292:265-70.
49. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. 1983. Lncap model of human prostatic-carcinoma. Cancer Res 43:1809-1818.
50. Huet G, Kim I, deBolos C, Lo-Guidice JM, Moreau O, Hemon B, Richet C, Delannoy P, Real FX, Degand P. 1995. Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation. J Cell Sci 108:1275-85.
51. Huh J-E, Jung I-T, Choi J, Baek Y-H, Lee J-D, Park D-S, Choi D-Y. 2013. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages. Eur J Pharmacol 698:57-66.
52. Ishisaka A, Kawabata K, Miki S, Shiba Y, Minekawa S, Nishikawa T, Mukai R, Terao J, Kawai Y. 2013. Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages. PLoS ONE 8:e80843.
53. Jaffe EA, Nachman RL, Becker CG, Minick CR. 1973. Culture of human endothelial cells derived from umbilical veins-Identification by morphologic and immunological criteria. J Clin Investig 52:2745-56.
54. Jailani F, Williamson G. 2014. Effect of edible oils on quercetin, kaempferol and galangin transport and conjugation in the intestinal Caco-2/HT29-MTX co-culture model. Food Funct 5:653-62.
55. Jin X, Yi L, Chen M-L, Chen C-Y, Chang H, Zhang T, Wang L, Zhu J-D, Zhang Q-Y, Mi M-T. 2013. Delphinidin-3-glucoside protects against oxidized low-density lipoprotein-induced mitochondrial dysfunction in vascular endothelial cells via the sodium-dependent glucose transporter SGLT1. PLoS One 8:e68617.
56. Juliano RL, Ling V. 1976. Surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152-62.
57. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. 1979. Establishment and characterization of a human prostatic-carcinoma cell-line (Pc-3). Invest Urol 17:16-23.
58. Karawajczyk A, Dran V, Medic N, Oboh G, Passamonti S, Novic M. 2007. Properties of flavonoids influencing the binding to bilitranslocase investigated by neural network modelling. Biochem Pharmacol 73:308-20.
59. Katsuno K, Fujimori Y, Takemura Y, Hiratochi M, Itoh F, Komatsu Y, Fujikura H, Isaji M. 2007. Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level. J Pharmacol Exp Ther 320:323-30.
60. Kim DH, Jung EA, Sohng IS, Han JA, Kim TH, Han MJ. 1998. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res 21:17-23.
61. Kim MK, Park KS, Yeo WS, Choo H, Chong Y. 2009. In vitro solubility, stability and permeability of novel quercetin-amino acid conjugates. Bioorg Med Chem 17:1164-71.
62. Kottra G, Daniel H. 2007. Flavonoid glycosides are not transported by the human Na+/glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake. J Pharmacol Exp Ther 322:829-35.
63. Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C, Williamson G. 2004. How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 80:15-21.
64. Kuntz S, Asseburg H, Dold S, Rompp A, Frohling B, Kunz C, Rudloff S. 2015. Inhibition of low-grade inflammation by anthocyanins from grape extract in an in vitro epithelial-endothelial co-culture model. Food Funct 6:1136-49.
65. Lambert N, Kroon PA, Faulds CB, Plumb GW, McLauchlan WR, Day AJ, Williamson G. 1999. Purification of cytosolic beta-glucosidase from pig liver and its reactivity towards flavonoid glycosides. BBA-Protein Struct M 1435:110-16.
66. LeBivic A, Hirn M, Reggio H. 1988. HT-29 cells are an in vitro model for the generation of cell polarity in epithelia during embryonic differentiation. Proc Natl Acad Sci USA 85:136-40.
67. Lee JW, Ahn JY, Hasegawa S, Cha BY, Yonezawa T, Nagai K, Seo HJ, Jeon WB, Woo JT. 2009. Inhibitory effect of luteolin on osteoclast differentiation and function. Cytotechnology 61:125-34.
68. Lee WS, Kanai Y, Wells RG, Hediger MA. 1994. The high-affinity Na+/glucose cotransporter - reevaluation of function and distribution of expression. J Biol Chem 269:12032-39.
69. Lenz W, Herten M, Gerzer R, Drummer C. 1999. Regulation of natriuretic peptide (urodilatin) release in a human kidney cell line. Kidney Int 55:91-99.
70. Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A. 1990. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50:6334-43.
71. Lesuffleur T, Barbat A, Luccioni C, Beaumatin J, Clair M, Kornowski A, Dussaulx E, Dutrillaux B, Zweibaum A. 1991. Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells. J Cell Biol 115:1409-18.
72. Lesuffleur T, Porchet N, Aubert J, Swallow D, Gum J, Kim Y, Real F, Zweibaum A. 1993. Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J Cell Sci 106:771-83.
73. Leuthold S, Hagenbuch B, Mohebbi N, Wagner CA, Meier PJ, Stieger B. 2009. Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. Am J Physiol Cell Physiol 296:C570-C82.
74. Liu Y, Hu M. 2002. Absorption and metabolism of flavonoids in the Caco-2 cell culture model and a perfused rat intestinal model. Drug Metab Dispos 30:370-77.
75. Lodi F, Winterbone MS, Tribolo S, Needs PW, Hughes DA, Kroon PA. 2012. Human quercetin conjugated metabolites attenuate TNF-alpha-induced changes in vasomodulatory molecules in an HUASMCs/HUVECs co-culture model. Planta Med 78:1571-3.
76. Macierzanka A, Rigby NM, Corfield AP, Wellner N, Bottger F, Mills ENC, Mackie AR. 2011. Adsorption of bile salts to particles allows penetration of intestinal mucus. Soft Matter 7:8077-84.
77. Maestro A, Terdoslavich M, Vanzo A, Kuku A, Tramer F, Nicolin V, Micali F, Decorti G, Passamonti S. 2010. Expression of bilitranslocase in the vascular endothelium and its function as a flavonoid transporter. Cardiovasc Res 85:175-83.
78. Mandery K, Bujok K, Schmidt I, Keiser M, Siegmund W, Balk B, Konig J, Fromm MF, Glaeser H. 2010. Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochem Pharmacol 80:1746-53.
79. McCool DJ, Forstner JF, Forstner GG. 1995. Regulated and unregulated pathways for MUC2 mucin secretion in human colonic LS180 adenocarcinoma cells are distinct. Biochem J 312:125-33.
80. Meier Y, Eloranta JJ, Darimont J, Ismair MG, Hiller C, Fried M, Kullak-Ublick GA, Vavricka SR. 2007. Regional distribution of solute carrier mRNA expression along the human intestinal tract. Drug Metab Dispos 35:590-94.
81. Menendez C, Duenas M, Galindo P, Gonzalez-Manzano S, Jimenez R, Moreno L, Zarzuelo MJ, Rodriguez-Gomez I, Duarte J, Santos-Buelga C, Perez-Vizcaino F. 2011. Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed? Mol Nutr Food Res 55:1780-90.
82. Mikkaichi T, Suzuki T, Onogawa T, Tanemoto M, Mizutamari H, Okada M, Chaki T, Masuda S, Tokui T, Eto N, Abe M, Satoh F, Unno M, Hishinuma T, Inui K, Ito S, Goto J, Abe T. 2004. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proc Natl Acad Sci USA 101:3569-74.
83. Mukai R, Ashida H, Terao J, Saito N, Shirai Y. 2011. Determination of subcellular localization of flavonol in cultured cells by laser scanning. In: Wang C, editor. Laser Scanning, Theory and Applications. INTECH Open Access Publisher. p 215-32.
84. Mukai R, Shirai Y, Saito N, Yoshida K, Ashida H. 2009. Subcellular localization of flavonol aglycone in hepatocytes visualized by confocal laser scanning fluorescence microscope. Cytotechnology 59:177-82.
85. Naomi O, Takashi H, Kazuki K. 2008. A possible mechanism that flavonoids exert anticarcinogenesis with activation of β-glucuronidase in cancerous tissues. In: Functional Food and Health. American Chemical Society. p 102-07.
86. Németh K, Plumb GW, Berrin J-G, Juge N, Jacob R, Naim HY, Williamson G, Swallow DM, Kroon PA. 2003. Deglycosylation by small intestinal epithelial cell β-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 42:29-42.
87. Nemeth K, Plumb GW, Berrin JG, Juge N, Jacob R, Naim HY, Williamson G, Swallow DM, Kroon PA. 2003. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 42:29-42.
88. Nies AT, Keppler D. 2007. The apical conjugate efflux pump ABCC2 (MRP2). Pflug Arch Eur J Physiol 453:643-59.
89. Nishitani Y, Yamamoto K, Yoshida M, Azuma T, Kanazawa K, Hashimoto T, Mizuno M. 2013. Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-κB inactivation in macrophages co-cultured with intestinal epithelial cells. Biofactors 39:522-33.
90. Nollevaux G, Deville C, El Moualij B, Zorzi W, Deloyer P, Schneider Y-J, Peulen O, Dandrifosse G. 2006. Development of a serum-free co-culture of human intestinal epithelium cell-lines (Caco-2/HT29-5M21). BMC Cell Biol 7:20.
91. Notas G, Nifli AP, Kampa M, Pelekanou V, Alexaki VI, Theodoropoulos P, Vercauteren J, Castanas E. 2012. Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells. J Nutr Biochem 23:656-66.
92. O'Leary KA, Day AJ, Needs PW, Mellon FA, O'Brien NM, Williamson G. 2003. Metabolism of quercetin-7-and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 65:479-91.
93. Oi N, Hashimoto T, Kanazawa K. 2008. Metabolic conversion of dietary quercetin from its conjugate to active aglycone following the induction of hepatocarcinogenesis in fisher 344 rats. J Agric Food Chem 56:577-83.
94. Passamonti S, Terdoslavich M, Franca R, Vanzo A, Tramer F, Braidot E, Petrussa E, Vianello A. 2009. Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr Drug Metab 10:369-94.
95. Passamonti S, Terdoslavich M, Margon A, Cocolo A, Medic N, Micali F, Decorti G, Franko M. 2005a. Uptake of bilirubin into HepG2 cells assayed by thermal lens spectroscopy - Bilitranslocase. FEBS J 272:5522-35.
96. Passamonti S, Vanzo A, Vrhovsek U, Terdoslavich M, Cocolo A, Decorti G, Mattivi F. 2005b. Hepatic uptake of grape anthocyanins and the role of bilitranslocase. Food Res Int 38:953-60.
97. Perez-Vizcaino F, Duarte J, Santos-Buelga C. 2012. The flavonoid paradox: conjugation and deconjugation as key steps for the biological activity of flavonoids. J Sci Food Agr 92:1822-25.
98. Pinto M, Robineleon S, Appay MD, Kedinger M, Triadou N, Dussaulx E, Lacroix B, Simonassmann P, Haffen K, Fogh J, Zweibaum A. 1983. Enterocyte-like differentiation and polarization of the human-colon carcinoma cell-line Caco-2 in culture. Biol Cell 47:323-30.
99. Prime-Chapman HM, Fearn RA, Cooper AE, Moore V, Hirst BH. 2004. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J Pharmacol Exp Ther 311:476-84.
100. Pulido MM, Molina AJ, Merino G, Mendoza G, Prieto JG, Alvarez AI. 2006. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. J Vet Pharmacol Ther 29:279-87.
101. Qiu J, Kitamura Y, Miyata Y, Tamaru S, Tanaka K, Tanaka T, Matsui T. 2012. Transepithelial transport of theasinensins through Caco-2 cell monolayers and their absorption in Sprague-Dawley rats after oral administration. J Agric Food Chem 60:8036-43.
102. Regina A, Koman A, Piciotti M, El Hafny B, Center MS, Bergmann R, Couraud PO, Roux F. 1998. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 71:705-15.
103. Riches Z, Stanley EL, Bloomer JC, Coughtrie MWH. 2009. Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT Pie. Drug Metab Dispos 37:2255-61.
104. Rodriguez-Mateos A, Toro-Funes N, Cifuentes-Gomez T, Cortese-Krott M, Heiss C, Spencer JPE. 2014. Uptake and metabolism of (-)-epicatechin in endothelial cells. Arch Biochem Biophys 559:17-23.
105. Roux F, Durieutrautmann O, Chaverot N, Claire M, Mailly P, Bourre JM, Strosberg AD, Couraud PO. 1994. Regulation of gamma-glutamyl-transpeptidase and alkaline-phosphatase activities in immortalized rat-brain microvessel endothelial-cells. J Cell Physiol 159:101-13.
106. Saeed B, Zhang HC, Ng SC. 1997. Apoptotic program is initiated but not completed in LNCaP cells in response to growth in charcoal-stripped media. Prostate 31:145-52.
107. Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F. 1995. Flavonoids as antioxidant agents-Importance of their interaction with biomembranes. Free Radic Biol Med 19:481-86.
108. Sambuy Y, Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. 2005. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21:1-26.
109. Scalbert A, Williamson G. 2000a. Dietary intake and bioavailability of polyphenols. J Nutr 130:2073s-85s.
110. Scalbert A, Williamson G. 2000b. Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S-85S.
111. Scheffer GL, Kool M, deHaas M, deVree JML, Pijnenborg ACLM, Bosman DK, Elferink RPJO, vander Valk P, Borst P, Scheper RJ. 2002. Tissue distribution and induction of human multidrug resistant protein 3. Lab Investig 82:193-201.
112. Schewe T, Steffen Y, Sies H. 2008. How do dietary flavanols improve vascular function? A position paper. Arch Biochem Biophys 476:102-06.
113. Schnitzer E, Pinchuk I, Lichtenberg D. 2007. Peroxidation of liposomal lipids. Eur Biophys J Biophy 36:499-515.
114. Schroeder P, Klotz L-O, Sies H. 2003. Amphiphilic properties of (-)-epicatechin and their significance for protection of cells against peroxynitrite. Biochem Biophys Res Commun 307:69-73.
115. Schumacher M, Hautzinger A, Rossmann A, Holzhauser S, Popovic D, Hertrampf A, Kuntz S, Boll M, Wenzel U. 2010. Chrysin blocks topotecan-induced apoptosis in Caco-2 cells in spite of inhibition of ABC-transporters. Biochem Pharmacol 80:471-79.
116. Sen CK, Bagchi D. 2001. Regulation of inducible adhesion molecule expression in human endothelial cells by grape seed proanthocyanidin extract. Mol Cell Biochem 216:1-7.
117. Shimoi K, Saka N, Nozawa R, Sato M, Amano I, Nakayama T, Kinae N. 2001. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab Dispos 29:1521-4.
118. Soler A, Romero MP, Macia A, Saha S, Furniss CSM, Kroon PA, Motilva MJ. 2010. Digestion stability and evaluation of the metabolism and transport of olive oil phenols in the human small-intestinal epithelial Caco-2/TC7 cell line. Food Chem 119:703-14.
119. Srivastava JK, Gupta S. 2009. Extraction, characterization, stability and biological activity of flavonoids isolated from chamomile flowers. Mol Cell Pharmacol 1:138-47.
120. Sun XY, Plouzek CA, Henry JP, Wang TTY, Phang JM. 1998. Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. Cancer Res 58:2379-84.
121. Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, Garberg P, Sjostrom B, Lundgren B, Artursson P. 2001. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 299:164-70.
122. Takano M, Yumoto R, Murakami T. 2006. Expression and function of efflux drug transporters in the intestine. Pharmacol Ther 109:137-61.
123. Tammela P, Laitinen L, Galkin A, Wennberg T, Heczko R, Vuorela H, Slotte JP, Vuorela P. 2004. Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles. Arch Biochem Biophys 425:193-99.
124. Tanaka J, Nakamura S, Tsuruma K, Shimazawa M, Shimoda H, Hara H. 2012. Purple rice (Oryza sativa L.) extract and its constituents inhibit VEGF-induced angiogenesis. Phytother Res 26:214-22.
125. Thilakarathna SH, Rupasinghe HPV. 2013. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 5:3367-87.
126. Thomas P, Smart TG. 2005. HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods 51:187-200.
127. Tian XJ, Yang XW, Yang XD, Wang K. 2009. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model. Int J Pharm 367:58-64.
128. Tsukamoto S, Yamashita S, Kim YH, Kumazoe M, Huang Y, Yamada K, Tachibana H. 2012. Oxygen partial pressure modulates 67-kDa laminin receptor expression, leading to altered activity of the green tea polyphenol, EGCG. FEBS Lett 586:3441-7.
129. Turco L, Catone T, Caloni F, Di Consiglio E, Testai E, Stammati A. 2011. Caco-2/TC7 cell line characterization for intestinal absorption: how reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human? Toxicol In Vitro 25:13-20.
130. Vafeiadou K, Vauzour D, Lee HY, Rodriguez-Mateos A, Williams RJ, Spencer JP. 2009. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 484:100-9.
131. Vafeiadou K, Vauzour D, Rodriguez-Mateos A, Whiteman M, Williams RJ, Spencer JP. 2008. Glial metabolism of quercetin reduces its neurotoxic potential. Arch Biochem Biophys 478:195-200.
132. Vaidyanathan JB, Walle T. 2003. Cellular uptake and efflux of the tea flavonoid (-)-epicatechin-3-gallate in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 307:745-52.
133. vanZanden JJ, vander Woude H, Vaessen J, Usta M, Wortelboer HM, Cnubben NHP, Rietjens IMCM. 2007. The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem Pharmacol 74:345-51.
134. Virgili F, Ambra R, Muratori F, Natella F, Majewicz J, Minihane AM, Rimbach G. 2003. Effect of oxidized low-density lipoprotein on differential gene expression in primary human endothelial cells. Antioxid Redox Signal 5:237-47.
135. Walgren RA, Lin JT, Kinne RK, Walle T. 2000a. Cellular uptake of dietary flavonoid quercetin 4′-beta-glucoside by sodium-dependent glucose transporter SGLT1. J Pharmacol Exp Ther 294:837-43.
136. Walgren RA, Lin JT, Kinne RKH, Walle T. 2000b. Cellular uptake of dietary flavonoid quercetin 4′-beta-glucoside by sodium-dependent glucose transporter SGLT1. J Pharmacol Exp Ther 294:837-43.
137. Walle T. 2004. Absorption and metabolism of flavonoids. Free Radic Biol Med 36:829-37.
138. Walsh KR, Failla ML. 2009. Transport and metabolism of equol by Caco-2 human intestinal cells. J Agric Food Chem 57:8297-302.
139. Wang XD, Meng MX, Gao LB, Liu T, Xu Q, Zeng S. 2009. Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp. Int J Pharm 378:1-8.
140. Wesolowska O, Wisniewski J, Sroda K, Krawczenko A, Bielawska-Pohl A, Paprocka M, Dus D, Michalak K. 2010. 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1. Eur J Pharmacol 644:32-40.
141. Wilhelm I, Fazakas C, Krizbai IA. 2011. In vitro models of the blood-brain barrier. Acta Neurobiol Exp 71:113-28.
142. Wilkening S, Stahl F, Bader A. 2003. Comparison of primary human hepatocytes and hepatoma cell line HEPG2 with regard to their biotransformation properties. Drug Metab Dispos 31:1035-42.
143. Wong CC, Akiyama Y, Abe T, Lippiat JD, Orfila C, Williamson G. 2012. Carrier-mediated transport of quercetin conjugates: Involvement of organic anion transporters and organic anion transporting polypeptides. Biochem Pharmacol 84:564-70.
144. Wu BJ, Kulkarni K, Basu S, Zhang SX, Hu M. 2011. First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci 100:3655-81.
145. Xiao JB, Suzuki M, Jiang XY, Chen XQ, Yamamoto K, Ren FL, Xu M. 2008. Influence of B-ring hydroxylation on interactions of flavonols with bovine serum albumin. J Agric Food Chem 56:2350-56.
146. Yang M, Butler M. 2000. Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. Biotechnol Bioeng 68:370-80.
147. Yi HW, Lu XM, Fang F, Wang J, Xu Q. 2008. Astilbin inhibits the adhesion of T lymphocytes via decreasing TNF-alpha and its associated MMP-9 activity and CD44 expression. Int Immunopharmacol 8:1467-74.
148. Yoshida H, Watanabe H, Ishida A, Watanabe W, Narumi K, Atsumi T, Sugita C, Kurokawa M. 2014. Naringenin suppresses macrophage infiltration into adipose tissue in an early phase of high-fat diet-induced obesity. Biochem Biophys Res Commun 454:95-101.
149. Yoshida H, Watanabe W, Oomagari H, Tsuruta E, Shida M, Kurokawa M. 2013. Citrus flavonoid naringenin inhibits TLR2 expression in adipocytes. J Nutr Biochem 24:1276-84.
150. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. 2004a. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 36:592-604.
151. Youdim KA, Shukitt-Hale B, Joseph JA. 2004b. Flavonoids and the brain: Interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 37:1683-93.
152. Zhang L, Lin G, Kovacs B, Jani M, Krajcsi P, Zuo Z. 2007a. Mechanistic study on the intestinal absorption and disposition of baicalein. Eur J Pharm Sci 31:221-31.
153. Zhang L, Zuo Z, Lin G. 2007b. Intestinal and hepatic glucuronidation of flavonoids. Mol Pharm 4:833-45.
154. Zhang Y, Song TT, Cunnick JE, Murphy PA, Hendrich S. 1999. Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J Nutr 129:399-405.